My mind wanders at times
during my nightly dose of Sports Center or a New York Knicks game. Call it a
morbid curiosity, but I think to myself, “are some of my favorite athletes
destined to die early due to the very same physical attribute that helped them
become a professional athlete in the first place?”
It’s a pretty macabre frame of mind to have while watching my
favorite basketball team drop the ball in yet another heartbreaking
fourth-quarter loss that resulted from a lack of offense down the stretch (then
again, maybe that’s what prompts these thoughts). But then I remember that some
of the tallest players in NBA history, including Gheorghe Muresan
(7 feet 7 inches) and Yao Ming (7 feet 6 inches), are still
alive and well. Manute Bol, standing at 7 feet 7 inches, is just as
tall as Muresan, and both are considered the tallest players in NBA history.
Bol, however, died
at 47 years old from
acute kidney failure and complications tied to Steven-Johnson
syndrome — a rare skin
disorder that was in no way related to his height.
At 7 feet 3 inches, Kristaps Porzingis is one of the
four tallest active NBA players. He’s also my favorite player, so, in his
honor, I decided to find out why tall people tend to die sooner.
Gigantism
and Acromegaly
Another unbelievably tall man was André René Roussimoff, but you
may know him as André the Giant. Unlike Bol, Roussimoff died at 46 years old because
of his height. Although he was only 7 feet 4 inches —
smaller than Muresan, Bradley, and Ming — he suffered from gigantism at an
early age, and eventually went on to develop acromegaly.
Gigantism
and acromegaly are not
the same disease, but they develop from the same region in the body, the
pituitary gland. In children, gigantism occurs when this gland, located near
the brain, produces an excessive amount of growth hormone (GH), which triggers
bones to grow in length at the growth plates, and causes subsequent, abnormal
growth spurts. Acromegaly is rare, and only occurs in adulthood. It’s also
characterized by the overproduction of GH; however, because growth plates fuse
after puberty, it is not associated with increases in height. In both
conditions, the overproduction of GH is due to a benign tumor that grows on the
pituitary gland.
Both diseases are treatable. In fact, four years ago, doctors at
the University of Virginia Medical Center successfully stopped acromegaly
patient Sultan Kosen —
the world’s tallest living man, standing at 8 feet 3 inches — from growing
with a novel form of radiation therapy, known as Gamma
Knife radiosurgery. Other treatments include surgery to remove the
tumor or administering medications that reduce GH production.
Unfortunately, identifying acromegaly is no walk in the park;
the most common symptom for both conditions is abnormally large hands or feet,
which can often be mistaken for swelling. Other symptoms, like increasingly
apparent facial features (thickened lips and protruding brows, for example), don’t
appear until the diseases have progressed. For this reason, many people with
the hormonal disorder fail to receive proper treatment, and end up suffering
from one of its many complications, such as arthritis, hypertension, heart
disease, diabetes, or cancer.
It’s these complications tied to acromegaly that are often the
cause of premature death (about
10 years earlier). In fact, one study found “around 60 percent of
acromegalic patients die from cardiovascular disease, 25 percent from
respiratory causes, and 15 percent from neoplasias,” or tumors. Such was the
case for Roussimoff, whose official cause of death was listed as heart failure.
Tall
People Without Gigantism or Acromegaly
Despite Porzingis not having either disease, my concern for his
health persists because research has shown even tall people without the
diseases face similar health risks. Specifically, research has shown that cross country skiers
are an average 6 inches shorter than basketball players, and that they tend to
live seven years longer. Centenarian Japanese people are even an average 4
inches shorter than those who reach 75, Slate reported.
Height is attributed to a bevy of different complications, the
most notable of which is cancer. A recent study from the Karolinska Institute
and the University of Stockholm showed that height is an immutable risk factor
for cancer. After looking at data for 5.5 million men and women living in
Sweden between 1938 and 1991, researchers found that for every four-inch bump
in height, overall cancer risk rose 18 percent in women and 11 percent in men.
Meanwhile, a similar study conducted by researchers from the
Albert Einstein College of Medicine found that tall postmenopausal women have a
13 percent higher cancer risk compared to their shorter counterparts.
Being taller is ideal in many Western cultures, especially for
men. But most people don’t realize that our height also affects the number of
cells in our bodies, as well as the size of our organs. And this can have a
tremendous effect on our health; having more cells increases a person’s chances
of receiving a cancer diagnosis.
The case against having larger organs continues — a larger heart,
also known as cardiomegaly,
is a condition that can lead to various complications, including heart
failure, blood clots, and sudden death. Taller people also face a higher chance
of respiratory illness, possibly because their lungs aren’t able to function as
efficiently.
While this might concern any tall people reading this, the fact
remains there’s nothing we can do about our height. We can’t stop ourselves
from growing, so there’s no point in worrying about how our height will affect
our mortality. That said, next time you find yourself sulking because you’re
the shortest member of your crew, remember that being the last to feel rainfall
could also mean you’ll be the last to kick the bucket.
0 comments:
Post a Comment